24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Earnings
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:27
Nice beats Q4 estimates but shares plunge on weak 2025 outlook
11:54
Can EU laws hold against Big Tech's power play?
11:40
Europe’s regulation-heavy reputation hides big opportunities for Israeli startups
10:31
From ‘Made in China’ to ‘Anywhere but China’
More stories
Buzz
Most popular
Daily
Weekly
1
Insight Partners hit by cyber attack with possible data leaks
2
Intel’s Israel operations hang in the balance as TSMC and Broadcom circle
3
Riskified cuts staff as struggles continue
4
CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move
5
Augury secures $75M at over $1B valuation to scale industrial AI
More news
Earnings
20 stories about Earnings
IFF's Frutarom Dream Hits Reality, Hard
17.02.20
|
Sophie Shulman
A little over a year after IFF's $6.4 billion acquisition of Israel-based Frutarom, its annual results for 2019 fail to deliver desired boost in sales
Teva’s Small Print Gives Rise to Optimism
13.02.20
|
Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
Verint to Split Into Two Companies: Cyber and Customer Engagement
05.12.19
|
Micky Grunfeld
Verint has a market capitalization of $3.2 billion on Nasdaq; the company rose 6.88% in after-hours trading following the announcement
Lemonade Releases Financial Data Following News of Shelved IPO
17.11.19
|
Hagar Ravet
The company reported annual recurring revenue of $104.4 million and a loss ratio of 78%
Teva Up 25% on NYSE Since Third Quarter Reports
17.11.19
|
Sophie Shulman
The Israeli drugmaker closed 8.74% up on Friday after a Cleveland County District judge reduced the fine placed on Johnson and Jonhson in Oklahoma by $107 million, citing a math error made in the original ruling
Fiverr Raises 2019 Revenue Guidance on Third Quarter Reports
14.11.19
|
Tzally Greenberg
The company published its earning reports Wednesday, announcing revenues that surpassed market expectations and losses lower than the analyst consensus
WeWork Continues Downward Spiral With $1.25 Billion in Losses for 3Q 2019
14.11.19
|
CTech
The New York Times and Bloomberg first reported the company has more than doubled its losses year-over-year
Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself
11.11.19
|
Uri Tal-Tene
With one anti-cancer biosimilar launching this week and another expected to hit the market soon, Teva could be creating a new growth engine worth hundreds of millions of dollars a year
Teva Announces $1.5 Billion Debt Tender Offer
10.11.19
|
Sophie Shulman
On Thursday, the Israeli drugmaker published its third quarter reports for 2019, reporting it had cut down its net debt to $25.7 billion
Despite Losses, Teva Pays Employee Bonuses for 2018
13.08.19
|
Hezi Sternlicht
Though Teva ended 2018 with a net loss of over $2.45 billion, the company awarded its employees with bonuses worth $390 million for the fiscal year’s results
Teva Beat Analysts’ Consensus, But Its Big Battles Are Still Up Ahead
08.08.19
|
Sophie Shulman
Teva ends the second quarter of 2019 down a CFO, with negative cash flow and the threat of lawsuits that could cost billions. In his call with analysts, CEO Kare Schultz hinted at the possibility of future layoffs, but Teva still handed out $240 million worth of annual bonuses to senior executives
Teva Beats Analysts on Second Quarter Operating Income, Revenues
07.08.19
|
CTech
The company also announced chief financial officer Michael McClellan will be stepping down after two years for personal reasons related to family
Just Before Nvidia Merger, Mellanox Reports 132% Increase in Net Income for Q2 2019
28.07.19
|
Tzally Greenberg
The Israeli chipmaker ended the second quarter of 2019 with a GAAP net income of $38.4 million and an almost 16% increase in revenue
Fitch Downgrades Teva, Keeps Outlook at Negative
10.06.19
|
Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
Fiverr Wants to Go Public According to a Post-IPO Valuation of $650 Million
03.06.19
|
Hagar Ravet and Sophie Shulman
The online gig marketplace is looking to raise $121 million in its initial public offering on NYSE, according to its new prospectus
Acquisition Approval Still Pending, Aeronautics Erases $23 Million Due to Accounting Mistake
29.05.19
|
Hezi Sternlicht
In April, Aeronautics’ board approved its sale to Israeli defense contractor Rafael according to a company valuation of $237 million
Teva’s Copaxone Successors Are Still Far From Success
05.05.19
|
Hezi Sternlicht
Teva’s first quarter report for 2019, published Thursday, shows that while the drugmaker is progressing with its financial rehabilitation program, its net debt to EBITDA ratio is leaving the company in dangerous waters
Check Point’s First Quarter: Revenues Slightly Up, Profit Slightly Down
18.04.19
|
Tzally Greenberg and Micky Grunfeld
The Nasdaq-listed network and cloud security provider published its first-quarter report for 2019 Thursday
Teva Execs Topped TASE's High Earners List for 2018
18.04.19
|
Gil Kalian
With nearly $34 million added to the bank, Teva’s CEO Kåre Schultz was the highest earning executive on the Tel Aviv Stock Exchange last year
Hot Off Acquisition Announcement, Mellanox Reports Record Revenues for 2019 Q1
17.04.19
|
Lilach Baumer
In March, Nvidia announced an agreement to buy the company for $6.9 billion, valuing it at $125 per share
Previous Articles
More Articles
